These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25761959)

  • 21. The genetic impact (C957T-DRD2) on inhibitory control is magnified by aging.
    Colzato LS; van den Wildenberg WP; Hommel B
    Neuropsychologia; 2013 Jun; 51(7):1377-81. PubMed ID: 23376770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency.
    Jacobsen LK; Pugh KR; Mencl WE; Gelernter J
    Psychopharmacology (Berl); 2006 Nov; 188(4):530-40. PubMed ID: 16896957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo.
    Hirvonen M; Laakso A; Någren K; Rinne JO; Pohjalainen T; Hietala J
    Mol Psychiatry; 2004 Dec; 9(12):1060-1. PubMed ID: 15278099
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity.
    Colzato LS; van den Wildenberg WP; Van der Does AJ; Hommel B
    Neuroscience; 2010 Oct; 170(3):782-8. PubMed ID: 20678555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linguistic grammar learning and DRD2-TAQ-IA polymorphism.
    Wong PC; Ettlinger M; Zheng J
    PLoS One; 2013; 8(5):e64983. PubMed ID: 23741438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach.
    Völter C; Riedel M; Wöstmann N; Aichert DS; Lobo S; Costa A; Schmechtig A; Collier DA; Hartmann AM; Giegling I; Möller HJ; Quednow BB; Rujescu D; Kumari V; Ettinger U
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1427-40. PubMed ID: 22244514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
    Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
    Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual differences in flow proneness are linked to a dopamine D2 receptor gene variant.
    Gyurkovics M; Kotyuk E; Katonai ER; Horvath EZ; Vereczkei A; Szekely A
    Conscious Cogn; 2016 May; 42():1-8. PubMed ID: 26954487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DRD2 C957T and TaqIA genotyping reveals gender effects and unique low-risk and high-risk genotypes in alcohol dependence.
    Swagell CD; Lawford BR; Hughes IP; Voisey J; Feeney GF; van Daal A; Connor JP; Noble EP; Morris CP; Young RM
    Alcohol Alcohol; 2012; 47(4):397-403. PubMed ID: 22582185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early postnatal experience and DRD2 genotype affect dopamine receptor expression in the rat ventral striatum.
    Lovic V; Belay H; Walker CD; Burton CL; Meaney MJ; Sokolowski M; Fleming AS
    Behav Brain Res; 2013 Jan; 237():278-82. PubMed ID: 23036844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients.
    Hoenicka J; Aragüés M; Rodríguez-Jiménez R; Ponce G; Martínez I; Rubio G; Jiménez-Arriero MA; Palomo T;
    Acta Psychiatr Scand; 2006 Dec; 114(6):435-8. PubMed ID: 17087792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated depressive symptoms enhance reflexive but not reflective auditory category learning.
    Maddox WT; Chandrasekaran B; Smayda K; Yi HG; Koslov S; Beevers CG
    Cortex; 2014 Sep; 58():186-98. PubMed ID: 25041936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
    Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
    Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in the dopamine D2 receptor gene plays a key role in human pain and its modulation by transcranial magnetic stimulation.
    Jääskeläinen SK; Lindholm P; Valmunen T; Pesonen U; Taiminen T; Virtanen A; Lamusuo S; Forssell H; Hagelberg N; Hietala J; Pertovaara A
    Pain; 2014 Oct; 155(10):2180-7. PubMed ID: 25180011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine modulates attentional control of auditory perception: DARPP-32 (PPP1R1B) genotype effects on behavior and cortical evoked potentials.
    Li SC; Passow S; Nietfeld W; Schröder J; Bertram L; Heekeren HR; Lindenberger U
    Neuropsychologia; 2013 Jul; 51(8):1649-61. PubMed ID: 23639477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging magnifies the effects of dopamine transporter and D2 receptor genes on backward serial memory.
    Li SC; Papenberg G; Nagel IE; Preuschhof C; Schröder J; Nietfeld W; Bertram L; Heekeren HR; Lindenberger U; Bäckman L
    Neurobiol Aging; 2013 Jan; 34(1):358.e1-10. PubMed ID: 22939506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.
    Kwak Y; Bohnen NI; Müller ML; Dayalu P; Burke DT; Seidler RD
    Behav Brain Res; 2013 May; 245():128-36. PubMed ID: 23439215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of l-Tyrosine on working memory and inhibitory control are determined by DRD2 genotypes: A randomized controlled trial.
    Colzato LS; Steenbergen L; Sellaro R; Stock AK; Arning L; Beste C
    Cortex; 2016 Sep; 82():217-224. PubMed ID: 27403851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism.
    Kunii Y; Miura I; Matsumoto J; Hino M; Wada A; Niwa S; Nawa H; Sakai M; Someya T; Takahashi H; Kakita A; Yabe H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():123-8. PubMed ID: 24704945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
    Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
    Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.